Consensus Enlivex Börse Stuttgart

Stocks

1BT

IL0011319527

Market Closed - Börse Stuttgart 15:56:00 2026-08-14 EDT			5-day change	1st Jan Change
1.370 ^EUR	-16.46%		-0.61%	-82.08%

07-28	Enlivex Ltd. announced that it expects to receive $400 million in funding	CI
07-13	Enlivex Receives FDA Regenerative Medicine Advanced Therapy Designation for Allocetra in Age-Related Knee Osteoarthritis	CI

Evolution of the Average Target: Enlivex

Evolution of the Target Price: Enlivex

Changes in Analyst Recommendations: Enlivex

77898f23844ff0343660b8.VW8f2iiF9KbS0vtSeCc5WEvyczujs2ORrjVQugdvdIw.HitnmBruxpS5m9YnQWFLEyGbIHP15iXExAEK-2soFvZmDkCiY_Ss9KCcrg~e643e46c0f8972e1370b17af91e99a81

Analysts' recommendations: Enlivex

24-06-11	HC Wainwright Adjusts Price Target on Enlivex Therapeutics to $6 From $7, Maintains Buy Rating	MT
24-04-12	HC Wainwright Adjusts Enlivex Therapeutics Price Target to $7 From $12, Maintains Buy Rating	MT
23-09-25	HC Wainwright Cuts Enlivex Therapeutics Price Target to $12 From $15, Maintains Buy Rating	MT
22-05-02	HC Wainwright Adjusts Enlivex Therapeutics' Price Target to $15 from $33, Keeps Buy Rating	MT

More recommendations

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

1.580USD

Average target price

80.00USD

Spread / Average Target

+4,963.29%

High Price Target

80.00USD

Spread / Highest target

+4,963.29%

Low Price Target

80.00USD

Spread / Lowest Target

+4,963.29%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

HC Wainwright

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

1.580USD

Average target price

80.00USD

Spread / Average Target

+4,963.29%

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

The best tools reserved for subscribers to boost the performance of your investments!

×